pharma letter lab workersThe Pharma Letter provides subscribers with daily, up-to-date news, business intelligence, comment and analysis for the Pharmaceuticals, Biotechnology and Generics sectors of the overall health care industry, backed by a team of respected writers with many years of experience in the field.

Register for free for our daily email newsletter and  to get access to premium content for 7 days free!

Latest Pharma Letter Articles

Pharmaceutical

features_upload_img_2

Positive Ph III results for Novo Nordisk's FIX derivative for hemophilia B

20 May 2013

Danish insulin giant Novo Nordisk (NOV: N) says it has completed paradigm 2, the first Phase

CIS countries prepare for the introduction of drug reimbursement schemes

20 May 2013

Russia, Ukraine and Kazakhstan have recently taken steps to introduce drug reimbursement schemes

Biotechnology

features_upload_img_3

Stallergenes and DBV Technologies partner on developing novel respiratory allergies treatments

20 May 2013

French biotech firms DBV Technologies (Euronext: DBV), creator of Viaskin, a new standard in

HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst

20 May 2013

While the risks involved in HIV vaccine development have turned Big Pharma away from pursuing

Generics

features_upload_img_4

Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law

20 May 2013

One of the most important preconditions for Turkey to reach a reformist, sustainable economic

Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines

20 May 2013

India's National Pharmaceutical Pricing Authority (NPPA) last week announced plans that will